BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4620828)

  • 1. [Prostaglandin F2alpha and the uterine musculature: bibliographic review and experimental contribution].
    Marmo E; Mastrantonio P; Caputi AP; Rossi F
    Arch Ostet Ginecol; 1974; 79(1-2):1-163. PubMed ID: 4620828
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the effects of some new derivatives of ethylenediamine on the cardiovascular system. Studies on general pharmacological properties.
    Filczewski M
    Acta Physiol Pol; 1974; 25(6):565-76. PubMed ID: 4456970
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin F2alpha is the uterine luteolytic hormone in the guinea pig: the evidence reviewed.
    Poyser NL
    Adv Prostaglandin Thromboxane Res; 1976; 2():633-43. PubMed ID: 790918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental analysis of the effects of PGE2 on uterine, intestinal and cardiac musculature and on striated muscle].
    Lampa E; Rosatti F; Imperatore A; Magliulo S; Giasi M; Spaziante G; Di Mezza G; Marmo E
    Arch Ostet Ginecol; 1979; 84(3-4):151-84. PubMed ID: 317990
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationships in the adrenergic-blocking agents.
    Ghouri MS; Haley TJ
    J Pharm Sci; 1969 May; 58(5):511-38. PubMed ID: 4389589
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of ryanodine.
    Jenden DJ; Fairhurst AS
    Pharmacol Rev; 1969 Mar; 21(1):1-25. PubMed ID: 4887724
    [No Abstract]   [Full Text] [Related]  

  • 7. PGF2alpha and nictitating membrane: an experimental study in vivo and in vitro.
    Marmo E; Saini RK; Lampa E; Caputi AP; Cazzola M; Rossi F
    Farmaco Prat; 1975 Jun; 30(6):291-301. PubMed ID: 1140378
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandins in clinical medicine.
    Yusuf SM
    J Pak Med Assoc; 1976 Feb; 26(2):28-34. PubMed ID: 817045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological studies of lithium salts. 3. General pharmacological action of LiCl on the cardiovascular system and smooth muscles].
    Ozawa H; Miyauchi T; Sugawara K; Sasajima M; Aihara H
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):215-30. PubMed ID: 4859054
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological studies of new indole alkaloids, rugulovasine A and B hydrochloride.
    Nagaoka A; Kikuchi K; Nagawa Y
    Arzneimittelforschung; 1972 Jan; 22(1):137-42. PubMed ID: 5066988
    [No Abstract]   [Full Text] [Related]  

  • 11. Some 2-bromobenzyl and 2,6-dimethylphenoxyethyl substituted sterically hindered amines.
    Dahlbom R; Johansson J; Pontén S
    Acta Pharm Suec; 1969 Jun; 6(3):413-8. PubMed ID: 5824856
    [No Abstract]   [Full Text] [Related]  

  • 12. Bamethan A competitive betamimetic drug.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental analysis of the effects of the anticoagulant fraction of Agkistrodon rhodostoma venom on the heart, the vascular and respiratory systems and on certain muscles].
    Mirmo E; Imperatore A; Chieppa S; Spaddaro R; Cazzola M; Somma A
    Minerva Cardioangiol; 1975 Oct; 23(10):648-74. PubMed ID: 1232572
    [No Abstract]   [Full Text] [Related]  

  • 14. [(Patho-)physiology and pharmacology of bradykinin and other plasma kinins. II].
    Ufkes JG; van der Meer C
    Ned Tijdschr Geneeskd; 1976 Jan; 120(4):147-52. PubMed ID: 942763
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prostaglandins and their biologic effects].
    Gajdos A
    Presse Med (1893); 1968 Mar; 76(11):513-6. PubMed ID: 5646254
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effects of compound IZ35 on the beta-adrenergic mediator system].
    Markov M; Zheliazkov D; Ivanov Ch
    Eksp Med Morfol; 1990; 29(4):33-9. PubMed ID: 1965891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular actions of cyclohexylammonium 3,6-pyridazinediolate.
    Tam L; Yen MH; Chow SY
    Taiwan Yi Xue Hui Za Zhi; 1975 Jul; 74(7):480-8. PubMed ID: 1059730
    [No Abstract]   [Full Text] [Related]  

  • 19. Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs.
    Fleming WW; McPhillips JJ; Westfall DP
    Ergeb Physiol; 1973; 68():55-119. PubMed ID: 4583341
    [No Abstract]   [Full Text] [Related]  

  • 20. Some pharmacological actions of acenocoumarin.
    Jindal MN; Shah DS
    Arzneimittelforschung; 1966 Jul; 16(7):878-81. PubMed ID: 6014718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.